|Bid||19.69 x 0|
|Ask||19.71 x 0|
|Day's Range||19.35 - 19.78|
|52 Week Range||16.18 - 21.38|
|Beta (5Y Monthly)||1.18|
|PE Ratio (TTM)||8.14|
|Earnings Date||May 02, 2022 - May 06, 2022|
|Forward Dividend & Yield||0.63 (3.64%)|
|Ex-Dividend Date||Aug 02, 2022|
|1y Target Est||24.38|
UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans, according to four people with knowledge of the matter. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, the sources said, asking for anonymity because the discussions were private. UnitedHealth had agreed to pay acquirers for Amil's loss-making units and lose money on the sale of the whole company, but did not receive an attractive proposal, the sources added.
LYG vs. BBD: Which Stock Is the Better Value Option?
French bank BNP Paribas SA has transferred its wealth management operation in Brazil to local rival Banco Bradesco SA , according to a securities filing and a letter to investors. The agreement to close its private bank in Brazil is a result of a "constant review of portfolio", a BNP letter to its clients said. The migration to Bradesco's private bank will happen over the next month.